Farudodstat
- Generic Name
- Farudodstat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H14F2N2O3
- CAS Number
- 1035688-66-4
- Unique Ingredient Identifier
- I58WE41H6X
- Background
Farudodstat (ASLAN003) is under investigation in clinical trial NCT03451084 (A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia).
- Associated Conditions
- -
- Associated Therapies
- -
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- ASLAN Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT05865041
- Locations
- 🇺🇸
1 Site, Webster, Texas, United States
🇺🇸2 Sites, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath